Tandem Diabetes Care, Inc. (TNDM) is an interesting player in the Healthcare space, with a focus on Medical Instruments & Supplies. The stock has been active on the tape, currently trading at $11.89, up from yesterday’s close by 6.68%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Tandem Diabetes Care, Inc. (TNDM) currently trades with a market capitalization of $531.48 Million. That value represents a market adjusting for revenues that have been growing by 43.74 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$61.19 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.35 on a per share basis this quarter. Perhaps, that suggests something about why 4.67% of the outstanding share supply is held by institutional investors.
No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Tandem Diabetes Care, Inc. recorded a 52-week high of $12.20. It is now trading 0.31% off that level. The stock is trading $6.29 its 50-day moving average by -5.6%. The stock carved out a 52-week low down at $2.14.
In recent action, Tandem Diabetes Care, Inc. (TNDM) has made a move of +55.42% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 15.83, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 5.33% with $37.69 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of TNDM.